Ironwood Pharmaceuticals (IRWD) Reports In-Line Q2 Loss
Tweet
Share
E-mailGet Alerts IRWD Hot Sheet
Join SI Premium – FREE
Ironwood Pharmaceuticals (NASDAQ: IRWD) reported Q2 loss of ($0.19), in-line with the analyst estimate of ($0.19). Revenue for the quarter came in at $11.26 million versus the consensus estimate of $10.83 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MillerKnoll, Inc. (MLKN) Tops Q4 EPS by 4c
- Accenture tumbles 16% on guidance cut; announces Dragos, runZero, NetRise deals
- Crown Crafts (CRWS) Reports Q4 EPS of $0.03
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
